Clinical Trial Detail

NCT ID NCT02952989
Title A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

SGN-2FF

Age Groups: senior adult

No variant requirements are available.